Three More States Introduce 340B Contract Pharmacy Protection Bills

Sen. Louise Lucas
Virginia state Sen. Louise Lucas this month introduced a 340B contract pharmacy bill. Influential state senators in Kentucky and Florida also recently introduced similar bills.
Influential state senators in Kentucky, Virginia, and Florida have introduced bills recently that would prohibit drug manufacturer restrictions on 340B [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2024 340B Contract Pharmacy Outlook: Expect More State Than Federal Action, Say Attorneys and Lobbyists

US Eighth Circuit Court of Appeals building
A decision upholding Arkansas' state contract pharmacy law from the U.S. 8th Circuit Court of Appeals could cause more states to push similar laws, attorneys and lobbyists said.
Amid expected congressional gridlock, there is a much higher likelihood of state legislative action on 340B contract pharmacies than federal [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Novo Says Arkansas Agreement ‘Preserves It’s Position’; More Manufacturer Deals in the Works

Arkansas Insurance Department office sign
The Arkansas Insurance Department will imminently enforce a state 340B contract pharmacy law following a key federal appeals court decision.
Drugmaker Novo Nordisk’s deal with Arkansas restoring 340B discounts in the contract pharmacy setting until a coming appeals court ruling, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2024 Congressional 340B Outlook: Overhaul Unlikely Without Major Legal Developments, Senate Deal

US Capitol
A Senate Committee recently approved the FY25 Departments of Labor, Health and Human Services, Education and Related Agencies Appropriations Act.
In 2024, congressional gridlock and election year dynamics will likely slow momentum on any comprehensive 340B program reform package, lobbyists [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Gilead Expands 340B Reporting to Wholly Owned Contract Pharmacies

Gilead exterior office sign
Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies wholly owned by covered entities.
Drugmaker Gilead Sciences will expand its data reporting requirements for 340B pricing on branded hepatitis C products to contract pharmacies [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

J&J Offers Refunds on Blockbuster Drug, Other Manufacturers Update NDCs

Johnson & Johnson building-mounted sign
Johnson & Johnson has ended its contract pharmacy restrictions for Arkansas covered entities.
Drugmaker Johnson & Johnson will offer refunds to 340B providers related to the purchases of four of its drugs, including [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

2023 Contract Pharmacy Developments: Surging Restrictions, State Law Legal Battles

In 2023, Arkansas became the first state to move to enforce a 340B contract pharmacy law as manufacturer restrictions continued to increase.
In 2023, the battle over the use of contract pharmacy arrangements by 340B providers was marked by increasing drugmaker restrictions, [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Louisiana, Health Centers Seek Dismissal of Contract Pharmacy Law Challenge

AstraZeneca headquarters
AstraZeneca will discontinue a certain bottle dosage of its breast cancer drug Truqap (capiversatib) by the end of the year but allow 340B covered entities to replenish their supply with an equivalent dose in blister pack package form.
Attorneys representing the state of Louisiana and 340B providers urged a federal judge to dismiss AstraZeneca’s lawsuit against Louisiana’s contract [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

Exclusive

Lilly to Conduct HRSA-Approved Audit That Includes First-Time Look for Medicaid MCO Duplicate Discounts

Lilly
Eli Lilly is conducting government approved 340B provider audits that for the first time look for certain Medicaid health plan duplicate discounts.
Federal regulators have approved a first-time 340B provider audit by a drug manufacturer to examine processes to prevent duplicate discounts [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »

News Alert

Takeda Becomes 29th Drugmaker to Implement 340B Contract Pharmacy Restrictions

Takeda 340B
Japanese drugmaker Takeda announced its cancer medication Ninlaro will be subject to its 340B contract pharmacy policy.
Japanese pharmaceutical giant Takeda last Friday became the 29th drugmaker to place conditions on 340B pricing in the contract pharmacy [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a
Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live